Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function

被引:0
作者
Yuichiro Kitai
Yohei Doi
Keisuke Osaki
Sayaka Sugioka
Masao Koshikawa
Akira Sugawara
机构
[1] Osaka Red Cross Hospital,Department of Nephrology
来源
Clinical and Experimental Nephrology | 2015年 / 19卷
关键词
Proteinuria; Type 2 diabetes; Diabetic nephropathy; Chronic kidney disease; Renal function decline; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1037 / 1043
页数:6
相关论文
共 167 条
[1]  
Guariguata L(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-149
[2]  
Whiting DR(2007)KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target Am J Kidney Dis 50 471-530
[3]  
Hambleton I(2000)Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate Diabetes 49 476-484
[4]  
Beagley J(1997)Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein J Am Soc Nephrol 8 1537-1545
[5]  
Linnenkamp U(2003)Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo J Clin Invest. 111 515-527
[6]  
Shaw JE(1999)Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome J Am Soc Nephrol 10 2323-2331
[7]  
Nosadini R(2007)Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes J Am Soc Nephrol 18 1353-1361
[8]  
Velussi M(1996)Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group Kidney Int. 50 1651-1658
[9]  
Brocco E(2004)Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL Kidney Int 65 2309-2320
[10]  
Bruseghin M(2005)Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients Diabetologia 48 2241-2247